Bayer | BAYN - Current Assets


Bayer reported EUR35.3B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Air Liquide EUR 9.99B 1.95B Dec/2025
Akzo Nobel EUR 7.53B 1.47B Mar/2026
Alcon AG USD 6.62B 171M Mar/2026
Amarin USD 626.02M 23.87M Mar/2026
Arkema EUR 4.84B 11.8M Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
BASF EUR 31.68B 1.4B Dec/2025
Bayer EUR 35.3B 2.39B Mar/2026
Beiersdorf EUR 6.66B 8M Dec/2025
Corteva USD 17.39B 50M Mar/2026
Covestro EUR 5.91B 259M Dec/2025
Essilor EUR 12.01B 981M Dec/2025
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GRIFOLS EUR 5.25B 180M Mar/2026
Henkel EUR 10.07B 268M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Johnson Matthey GBP 3.94B 105M Jun/2026
Linde USD 13.32B 6M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 14.16B 932M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Nutrien USD 16.48B 1.73B Mar/2026
Philips EUR 9.78B 148M Mar/2026
PPG Industries USD 7.97B 11M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
SAP EUR 22.26B 2B Mar/2026
Solvay EUR 2.19B 34M Mar/2026
UCB EUR 6.05B 733M Dec/2025
Umicore EUR 5.74B 881.2M Dec/2025
Vinci EUR 49.55B 1.99B Dec/2025